Workforce Roundtable Part 1: Recruiting Biopharma Leaders As The Talent Pool Shrinks And Diversifies
As Baby Boomers age out of the workforce, they'll be replaced in biopharma C-suites and boardrooms by a younger, more female and racially diverse group. A panel of current and former life science CEOs, venture investors and recruiters discuss the challenges and opportunities ahead.
You may also be interested in...
Workforce Roundtable Part 3: Diversity And Progress – And Advice For Biopharma's Next Generation
Women in leadership roles has become a much discussed issue for the biopharma industry, but less attention seems to be focused on racial diversity. Scrip's panel talks about challenges and opportunities, and offers advice for next generation employees.
Workforce Roundtable Part 2: Creating A 'Sticky' Workplace, Boardroom Roles For Women, Millennials
Once you've created an attractive company culture for women and millennials, what else should be done to retain the next generation of biopharma leaders? For starters, Scrip's panelists say, give them opportunities to contribute – including in the boardroom - and be open to new ways of communication.
Cerulean Shifts From Ovarian Cancer To Contraceptives In Reverse Merger With Daré
Cerulean and privately-held Daré entered into a stock purchase agreement that will give the latter company's shareholders a majority stake in the combined company, which will focus on women's health – particularly contraceptives – instead of the former firm's nanoparticle-drug conjugates for cancer.